Filing Details
- Accession Number:
- 0001104659-22-041749
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-01 16:16:39
- Reporting Period:
- 2022-03-30
- Accepted Time:
- 2022-04-01 16:16:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1173281 | Neubase Therapeutics Inc. | NBSE | Pharmaceutical Preparations (2834) | 465622433 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1819276 | Roland William Mann | C/O 350 Technology Drive, Fourth Floor Pittsburgh PA 15219 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-30 | 6,200 | $1.92 | 11,200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
